Autres langues ALS Limited

Actions

Temps Différé Australian S.E. Autres places de cotation 06:09:36 30/04/2024			Varia. 5j.	Varia. 1 janv.
13,14 ^AUD	-0,87%		-1,06%	+2,18%

02/04	ALS LIMITED : Morgans Financial abaisse son opinion à neutre	ZM
26/03	ALS LIMITED : Jarden Research à l'achat	ZM

ALS to Acquire Nuvisan; Shares Down 5%	25/03
ALS Limited agreed to acquire YORK Analytical Laboratories, Inc.	25/03
ALS Limited agreed to acquire Wessling Holding Gmbh & Co.Kg.	25/03
ALS Limited agreed to acquire the remaining 51% stake in Nuvisan Pharma Holding Gmbh.	25/03
Rimfire Pacific Mining Completes Air Core Drilling at Murga Project	18/03
ALS Limited Appoints Stuart Hutton as Chief Financial Officer, Effective 1 February 2024	20/12
Nieuwe aankopen voor de Aziatische portefeuille	16/12
Neue Käufe im InvestorPortfolio Asien	15/12
Nuevas compras en la cartera Inversor Asia	14/12
Nuovi acquisti nel portafoglio Asia	14/12
New entries in the Investor Asia portfolio	14/12
Australian Shares Rise as Investors Await US Inflation Data for Rate Hike Clues	14/11
ALS Trims Interim Dividend as Fiscal H1 Profit Declines; CFO to Step Down; Shares Up 6%	14/11
Australian shares rise on broad-based gains; CBA inches higher	14/11
ALS Limited acquired 85.6% stake in Indtech Instruments Private Limited for AUD 18.6 million.	14/11
ALS Limited Announces Stepdown of Luis Damasceno as Chief Financial Officer, Effective 19 January 2024	13/11
ALS Limited Appoints Heike Truöl as Chief Strategy Officer	13/11
Als Limited Announces Interim Dividend for the Period of Six Months Ending 30 September 2023, Payable on 14 December 2023	13/11
ALS Limited Reports Earnings Results for the Half Year Ended September 30, 2023	13/11
ALS Limited acquired 100% stake in Proanaliz Group of Laboratories for AUD 5.1 million.	09/08/23

Aucun résultat pour cette recherche

ALS Limited : Au cœur des industries sous l’œil de l’analyse

Le 03 mai 2023 à 15:16